DeFi protocol Injective to launch Layer 3 on Arbitrum

Injective is launching a Layer 3 network powered by Arbitrum’s Layer 2 scaling solution technology.
The DeFi protocol’s plan could attract capital from investors and improve the state of the INJ token in 2024.
INJ market capitalization shrunk to half of its $4.5 billion peak in 2023.

Injective (INJ) had a market capitalization of close to $4.5 billion at its peak in March 2023. At nearly half its market cap, the DeFi protocol has proposed a solution, likely to reinstate INJ to its former glory through higher relevance and fresh capital injection.

Injective plans to launch a Layer 3 chain on Arbitrum, using its Orbit toolkit that allows developers to build customizable chains.

Injective to launch Layer 3 chain powered by Arbitrum

Injective’s inEVM is compatible with the Ethereum Virtual Machine and connects Ethereum, Solana and Cosmos networks. The solution planned by Injective will use Arbitrum’s Orbit toolkit to customize a Layer 3 chain. The move could likely boost Injective’s importance among market participants, likely driving demand and fresh capital injection to the project.

According to a Cointelegraph report, the integration would offer developers the opportunity to build within the Ethereum Layer 2 ecosystem, with the benefit of Injective’s high speed and relatively low fees, compared to other Layer 2 chains.

The inEVM network (Injective’s proposed Layer 3 chain) will reduce the circulating supply of the INJ token by aggregating and systematically burning a percentage of all protocol fees on a weekly basis.

A reduction in circulating supply is typically considered bullish for an asset, and it could drive gains in INJ price.

At the time of writing, INJ is down 4% on the day. The DeFi token is exchanging hands at $23.68 on Binance.

Share: Cryptos feed

Information on these pages contains forward-looking statements that involve risks and uncertainties. Markets and instruments profiled on this page are for informational purposes only and should not in any way come across as a recommendation to buy or sell in these assets. You should do your own thorough research before making any investment decisions. FXStreet does not in any way guarantee that this information is free from mistakes, errors, or material misstatements. It also does not guarantee that this information is of a timely nature. Investing in Open Markets involves a great deal of risk, including the loss of all or a portion of your investment, as well as emotional distress. All risks, losses and costs associated with investing, including total loss of principal, are your responsibility. The views and opinions expressed in this article are those of the authors and do not necessarily reflect the official policy or position of FXStreet nor its advertisers. The author will not be held responsible for information that is found at the end of links posted on this page.

If not otherwise explicitly mentioned in the body of the article, at the time of writing, the author has no position in any stock mentioned in this article and no business relationship with any company mentioned. The author has not received compensation for writing this article, other than from FXStreet.

FXStreet and the author do not provide personalized recommendations. The author makes no representations as to the accuracy, completeness, or suitability of this information. FXStreet and the author will not be liable for any errors, omissions or any losses, injuries or damages arising from this information and its display or use. Errors and omissions excepted.

The author and FXStreet are not registered investment advisors and nothing in this article is intended to be investment advice.

Join Telegram